The exclusive, first-hand, behind-the-scenes story of how Pfizer raced to create the first Covid-19 vaccine, told by Pfizer's CEO Dr. Albert Bourla A riveting, fast-paced, inside look at one of the most incredible private sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr. Albert Bourla, made "the impossible possible"--creating, testing, and manufacturing a safe and effective Covid-19 vaccine that previously would have taken years to develop. Dr. Bourla chronicles how the brilliant, dedicated minds at Pfizer, under the enormous strains of the global pandemic, overcame a series of crises that were compounded by social and political unrest, and reveals the doubts, decisions, obstacles, and failures they encountered. As Dr. Bourla makes clear, Pfizer's success wasn't due to luck; it was because of preparation driven by four simple values--Courage, Excellence, Equity, and Joy. Moonshot is a story of leadership under the most unprecedented circumstances--how Dr. Bourla, a Greek immigrant, a child of Holocaust survivors, and a veterinarian, became the head of one of the world's largest corporations and initiated a dramatic transformation of the organization just before a global health crisis would serve to test the organization, its scientists and its leader, like never before. Moonshot describes best practices that can be used to address the multiple, unprecedented challenges our world faces, reveals Pfizer's implementation of scientific breakthroughs at a record-breaking pace, and offers leadership lessons that can help anyone successfully manage their own seemingly unsolvable problems. As Dr. Bourla explains, "I am sharing the story of our moonshot--the challenges we faced, the lessons we learned, and the core values that allowed us to make it happen--in hopes that it might inspire and inform your own moonshot, whatever that may be."

THE 49TH VOLUME OF THE ANNUAL REVIEW OF ENTOMOLOGY FOR 2004

This work has been selected by scholars as being culturally important and is part of the knowledge base of civilization as we know it. This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. To ensure a quality reading experience, this work has been proofread and republished using a format that seamlessly blends the original graphical elements with text in an easy-to-read typeface. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.

It is remarkable that each month the quantity ofarticles published on AIDS still that address numbers in the thousands. The basic, clinical and sociological aspects this epidemic have been vigorously investigated, and equally as extensively reported in traditional as well as new journals. Therefore, what can the reader ofthis volume expect to find that is different from the information already found in the literature? The authors of this text met in October 1993 to discuss not only AIDS and its effects on the nervous system but also to address the problem from the point of view of the diverse technologies that are used in understanding the disease. Just as the recog nition ofoncogenic viruses gave us insights into cellular genes that govern growth, the study ofHIV-I in the nervous system has opened new areas ofinvestigation in the nervous system. Use of human fetal and glioma-derived cell cultures, discovery of toxins in the nervous system, release and damage of cytokines in the brain, the neuropathic effects of HIV proteins, the investigation of new treatment for neuro AIDS, and virus detection strategies to identify latent HIVI infection are described in this volume. Basic and clinical investigators from more than thirty laboratories around the world contributed to the ideas discussed at the meeting, "Technical Advances in AIDS Research in the Human Nervous System.